These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

230 related articles for article (PubMed ID: 18243660)

  • 1. Immunophenotype and functional characteristics of human primitive CD34-negative hematopoietic stem cells: the significance of the intra-bone marrow injection.
    Sonoda Y
    J Autoimmun; 2008 May; 30(3):136-44. PubMed ID: 18243660
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Equal distribution of competitive long-term repopulating stem cells in the CD34+ and CD34- fractions of Thy-1lowLin-/lowSca-1+ bone marrow cells.
    Morel F; Galy A; Chen B; Szilvassy SJ
    Exp Hematol; 1998 May; 26(5):440-8. PubMed ID: 9590662
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Microarray and serial analysis of gene expression analyses identify known and novel transcripts overexpressed in hematopoietic stem cells.
    Georgantas RW; Tanadve V; Malehorn M; Heimfeld S; Chen C; Carr L; Martinez-Murillo F; Riggins G; Kowalski J; Civin CI
    Cancer Res; 2004 Jul; 64(13):4434-41. PubMed ID: 15231652
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hematopoietic stem cells from different sources: biological and technical aspects.
    Bertolini F; Battaglia M; Lanza A; Palermo B; Cuomo A; Preti P; Robustelli della Cuna G
    Bone Marrow Transplant; 1998 Apr; 21 Suppl 2():S5-7. PubMed ID: 9630315
    [TBL] [Abstract][Full Text] [Related]  

  • 5. CD34- hematopoietic stem cells: current concepts and controversies.
    Guo Y; Lübbert M; Engelhardt M
    Stem Cells; 2003; 21(1):15-20. PubMed ID: 12529547
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hematopoietic stem cells from fancc(-/-) mice have lower growth and differentiation potential in response to growth factors.
    Aubé M; Lafrance M; Charbonneau C; Goulet I; Carreau M
    Stem Cells; 2002; 20(5):438-47. PubMed ID: 12351814
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Rapid myeloerythroid repopulation after intrafemoral transplantation of NOD-SCID mice reveals a new class of human stem cells.
    Mazurier F; Doedens M; Gan OI; Dick JE
    Nat Med; 2003 Jul; 9(7):959-63. PubMed ID: 12796774
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Who is hematopoietic stem cell: CD34+ or CD34-?
    Pei X
    Int J Hematol; 1999 Dec; 70(4):213-5. PubMed ID: 10643145
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Differential regulation of the human and murine CD34 genes in hematopoietic stem cells.
    Okuno Y; Iwasaki H; Huettner CS; Radomska HS; Gonzalez DA; Tenen DG; Akashi K
    Proc Natl Acad Sci U S A; 2002 Apr; 99(9):6246-51. PubMed ID: 11983914
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparison of various bone marrow fractions in the ability to participate in vascular remodeling after mechanical injury.
    Sahara M; Sata M; Matsuzaki Y; Tanaka K; Morita T; Hirata Y; Okano H; Nagai R
    Stem Cells; 2005 Aug; 23(7):874-8. PubMed ID: 15941860
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Absence of a CD34- hematopoietic precursor population in recipients of CD34+ stem cell transplantation.
    Kato S; Ando K; Nakamura Y; Muguruma Y; Sato T; Yabe H; Yabe M; Hattori K; Yasuda Y; Hotta T
    Bone Marrow Transplant; 2001 Sep; 28(6):587-95. PubMed ID: 11607772
    [TBL] [Abstract][Full Text] [Related]  

  • 12. SCID-repopulating cell activity of human cord blood-derived CD34- cells assured by intra-bone marrow injection.
    Wang J; Kimura T; Asada R; Harada S; Yokota S; Kawamoto Y; Fujimura Y; Tsuji T; Ikehara S; Sonoda Y
    Blood; 2003 Apr; 101(8):2924-31. PubMed ID: 12480697
    [TBL] [Abstract][Full Text] [Related]  

  • 13. CD34(+) or CD34(-): which is the more primitive?
    Engelhardt M; Lübbert M; Guo Y
    Leukemia; 2002 Sep; 16(9):1603-8. PubMed ID: 12200670
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Allogeneic hematopoietic stem cells from sources other than bone marrow: biological and technical aspects.
    Bertolini F; de Vincentiis A; Lanata L; Lemoli RM; Maccario R; Majolino I; Ponchio L; Rondelli D; Tabilio A; Zanon P; Tura S
    Haematologica; 1997; 82(2):220-38. PubMed ID: 9175330
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Determinants of skeletal muscle contributions from circulating cells, bone marrow cells, and hematopoietic stem cells.
    Sherwood RI; Christensen JL; Weissman IL; Wagers AJ
    Stem Cells; 2004; 22(7):1292-304. PubMed ID: 15579647
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Developmental potentials of hematopoietic and neural stem cells following injection into pre-implantation blastocysts.
    Harder F; Kirchhof N; Petrovic S; Schmittwolf C; Dürr M; Müller AM
    Ann Hematol; 2002; 81 Suppl 2():S20-1. PubMed ID: 12611062
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Identification and hematopoietic potential of CD45- clonal cells with very immature phenotype (CD45-CD34-CD38-Lin-) in patients with myelodysplastic syndromes.
    Ogata K; Satoh C; Tachibana M; Hyodo H; Tamura H; Dan K; Kimura T; Sonoda Y; Tsuji T
    Stem Cells; 2005 May; 23(5):619-30. PubMed ID: 15849169
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Evidence of peripheral blood-derived, plastic-adherent CD34(-/low) hematopoietic stem cell clones with mesenchymal stem cell characteristics.
    Huss R; Lange C; Weissinger EM; Kolb HJ; Thalmeier K
    Stem Cells; 2000; 18(4):252-60. PubMed ID: 10924091
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Long-term lymphohematopoietic reconstitution by a single CD34-low/negative hematopoietic stem cell.
    Osawa M; Hanada K; Hamada H; Nakauchi H
    Science; 1996 Jul; 273(5272):242-5. PubMed ID: 8662508
    [TBL] [Abstract][Full Text] [Related]  

  • 20. CD34 antigen: molecular features and potential clinical applications.
    Sutherland DR; Stewart AK; Keating A
    Stem Cells; 1993 Oct; 11 Suppl 3():50-7. PubMed ID: 7507757
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.